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In Brief
Treg cells can derive from either thymic or peripheral sources and can undergo further differentiation into an effector state in response to environmental cues. Dias and colleagues demonstrate that Myb is specifically required for the differentiation of thymus-derived effector Treg cells that play a non-redundant role in controlling immune homeostasis.
INTRODUCTION
Regulatory T (Treg) cells are vital to the preservation of immune tolerance and prevention of exacerbated immune responses to foreign antigens. Treg cells also promote therapeutic tolerance to transplanted organs and can influence the ability of tumor cells or certain pathogens to escape immune surveillance by dampening the immune response (Josefowicz et al., 2012a) . The transcription factor FoxP3 is required for the generation, identity, and suppressive function of CD4 + Treg cells, and loss-of-function mutations in its encoding gene are sufficient to trigger fatal systemic autoimmunity in both mice and humans (Rudensky, 2011) . Referred to as thymus-derived Treg (tTreg) cells, the majority of Treg cells are generated in the thymus and are exported to the periphery as FoxP3-expressing cells with suppressive capacity. FoxP3 expression can also be induced in peripheral CD4 + T cells, and these peripheral Treg (pTreg) cells are, at least in homeostatic conditions, distinguished from tTreg cells by the lack of surface neuropilin-1 (Nrp1) (Weiss et al., 2012) and the transcription factor Helios (Thornton et al., 2010) . tTreg cells and pTreg cells are thought to play complementary roles in the regulation of the immune system (Haribhai et al., 2011; Josefowicz et al., 2012b) . Naive Treg cells can undergo further differentiation in response to antigen (Levine et al., 2014; Vahl et al., 2014 ) and a variety of environmental cues, resulting in acquisition of distinct phenotypes and effector molecules (Cretney et al., 2013) . The proto-oncogene myeloblastosis (Myb) is a transcription factor implicated in the differentiation of multiple cell types (Greig et al., 2008) . Myb acts at several stages during thymopoiesis to promote the proliferation and or survival of specific T cell subsets (Allen et al., 1999; Bender et al., 2004; Lieu et al., 2004) . Myb is required for natural killer T (NKT) cell generation and promotes the development of CD4 + T cells in the thymus through a GATA3-dependent mechanism (Hu et al., 2010; Maurice et al., 2007) . Although Myb expression is downregulated in all mature T cells, it is transiently upregulated upon T cell receptor activation in vitro (Bich-Thuy et al., 1987) . MYB is required for the proper polarization of human CD4 + T cells under T helper 2 (Th2) cell differentiation conditions in vitro (Nakata et al., 2010) , and its expression is altered in autoimmune diseases (Gustafsson et al., 2015) . Although it has been unclear whether Myb is also required for Treg cell differentiation, we reasoned that this is a likely scenario given that Myb-deficient CD4 + CD8
+ doublepositive (DP) precursors overexpress CD25 (Lieu et al., 2004) , a specific marker of Treg cells. Furthermore, in silico approaches have identified Myb binding sites as the most significantly enriched DNA sequences in the proximity of Treg-cell-specific regulatory regions , and MYB has also been identified in a screen for transcription factor binding sites that co-localize with FoxP3 binding sites in human Treg cells (Sadlon et al., 2010) . Here, we show that Myb is dispensable for Treg cell differentiation in the thymus but required for tTreg cell homeostasis in the periphery. In contrast, pTreg cells neither expressed nor required Myb for their differentiation. Myb was induced in tTreg cells upon activation, and the deletion of Myb in Treg cells resulted in the spontaneous development of a fatal multi-organ inflammatory disease. Myb bound to the regulatory regions of many genes important in Treg cell biology and was required for optimal proliferation of effector Treg cells. Our findings demonstrate that Myb activity is deeply embedded in the transcriptional program of effector Treg cell differentiation. Figure 1A and data not shown). Myb deletion did not alter the proportion of FoxP3 + Treg cells among thymus CD4 + T cells, given that
RESULTS

Myb
Treg cell numbers were reduced proportionally to CD4 + thymocytes without Myb ( Figure 1A) . A different scenario emerged outside the thymus, where Myb-deficient Treg cells were under-represented both in absolute cell number and as a proportion of CD4 + T cells in the circulation, spleen, liver, and lung, Figure 2A) . Importantly, the previously described miR150 binding sites in the 3 0 UTR were left intact, allowing for the regulation of Myb by this microRNA (Xiao et al., 2007) . Homozygous Myb GFP mice were viable and healthy and had normal frequencies of B and T lymphocytes (data not shown). As predicted from earlier studies, Myb GFP was highly and uniformly expressed in populations enriched with hematopoietic stem cells and common lymphoid progenitors (Greig et al., 2008) , as well as CD4 + thymocytes (Figures S1A and S1B (Herman et al., 2004; Ito et al., 2008) , most prominently in the liver and lung ( Figures 2B and S2D ). Furthermore, Treg cells stimulated in vitro with anti-CD3 and anti-CD28 in the presence of interleukin-2 (IL-2) upregulated ICOS and Myb GFP expression ( Figure 2C ). In contrast, Myb GFP was not expressed in in-vitro-polarized induced Treg (iTreg) cells ( Figure 2D ). Thus, Myb GFP is specifically expressed in ICOS + effector Treg cells generated in vivo.
Myb-Deficient Treg Cells Lack Multiple Effector Molecules
The highly restricted expression of Myb to ICOS + effector Treg cells raises the possibility that Myb activity is specifically required for the differentiation of these cells. Indeed, we found a reduced proportion of ICOS + Treg cells in the absence of Myb in a variety of organs, with the notable exception of the LNs ( Figures 3A-3C and S2A-S2C). The loss of ICOS expression in Treg cells in the absence of Myb could be due to the requirement for Myb for the transcription of the Icos locus or reflect the reduced representation of the effector Treg cell subset. To distinguish between these possibilities, we analyzed the expression of additional effector molecules. We found that Myb-deficient Treg cells were able to downregulate CD62L and upregulate CD44 and therefore achieve an activated state ( Figures 3A, 3B , S2A, and S2B). Surface expression of the immune receptor TIGIT in Treg cells correlates with their effector functions (Joller et al., 2014) , and KLRG1-expressing Treg cells are a subset of short-lived terminally differentiated cells with an effector signature (Cheng et al., 2012 Figures 3D and 3E ). These results suggests that, under steady-state conditions, most ICOS + Treg cells in the spleen and pLNs are tTreg cells, whereas in the mLNs they are predominantly pTreg cells (Weiss et al., 2012) .
A different picture emerged when we analyzed Nrp1 expression in Myb fl/fl Cd4cre Tg mice, where we found a prominent contribution of Nrp1 À cells to the ICOS + pool in the LNs, but not in the spleen, liver, or lung ( Figures 3E and S2C ). Expression of Helios, an independent marker of tTreg cells (Thornton et al., 2010) , followed the same trend ( Figures S2D-S2F 
Cd4cre
Tg mice showed no signs of clinical disease. Because previous work has suggested that Myb also plays a role in mature conventional T cells (Lieu et al., 2004; Nakata et al., 2010) and that Myb deficiency ablates the NKT cell population (Hu et al., 2010) , it is possible that the pathological manifestations of Treg-cell-intrinsic defects in Myb fl/fl Cd4cre Tg mice were being masked by defects in other cell types. To ascertain the physiological relevance of Myb activity in Treg cells, we generated Myb fl/fl Foxp3 YFP-cre mice, where Myb was specifically deleted in Treg cells, simultaneously traceable by YFP. These mice spontaneously developed a multi-organ inflammatory disease with early onset and lethality by $6 months of age (Figure 4A) . Myb fl/fl Foxp3 YFP-cre mice failed to gain weight and showed an enlarged spleen, neutrophilia, and chronic anemia Figure 5D ), known to be essential for the suppressive capacity of Treg cells in vivo (Wing et al., 2008) .
It was recently shown that the initial wave of Treg cells, generated within the first 10 days after birth, have functional properties distinct from those of adult Treg cells (Yang et al., 2015 5F , and S4D), suggesting that Myb is essential for the establishment of a tolerogenic environment in neonates. All together, these results support the conclusion Figures S5A and S5B ). Follicular T helper (Tfh) cells were also detected in the mediastinal LNs of both WT and Myb-deficient influenza-infected mice ( Figures S5C and S5D ).
In vitro polarization and proliferation of CD4 + T cells in Th1, Th2, and Th17 cell differentiation conditions were also unaffected by Myb loss ( Figure S5E ). These results indicate that Myb is dispensable for the generation of effector CD8 + and CD4 + T cell subsets, at least in response to acute viral infection, although whether these effector populations are fully functional remains to be experimentally determined.
GATA3 Induction in Effector Treg Cells Depends on Myb
GATA3 is induced when Treg cells become activated and is required for Treg cell suppressor function, although possibly only under specific physiological circumstances (Wang et al., 2011; Wohlfert et al., 2011; Yu et al., 2015) . The transcription factor T-bet is also expressed in a subset of Treg cells with an activated phenotype and is important for the maintenance of Treg cell homeostasis (Koch et al., 2009 Figure S6C ). Pairwise comparisons among all three WT subpopulations revealed 4,107 differentially expressed (DE) genes, the vast majority (94%) of which were expressed at an intermediate rate in activated Treg cells ( Figure 6A ). It was also clear that more genes differed, and to a higher degree, between effector and naive Treg cells than between activated and naive Treg cells or between activated and effector subpopulations, suggesting a hierarchical relationship among naive, activated, and effector Treg cells ( Figure 6B ). To investigate the extent to which Myb directly regulates gene expression in Treg cells, we applied a procedure termed digital genomic footprinting, developed by the ENCODE Consortium (Neph et al., 2012) and recently used to map MYB binding sites in human blood cell types (Bengtsen et al., 2015) . We utilized two existing genome-wide DNase I hypersensitivity (DHS) datasets encompassing total splenic Treg cells (termed steady-state Treg cells) and in-vivo-activated Treg cells that result from the inflammatory environment elicited by the transient depletion of Treg cells ENCODE Project Consortium, 2012) . The DNase I genomic footprints were downloaded from ENCODE and used for de novo discovery of Myb-binding motifs. Myb digital genomic footprints (DGFs) were assigned to genes if they occurred within 20 kb upstream of the transcriptional start site and 5 kb downstream of the 3 0 UTR. Within these criteria, multiple gene assignments for individual Myb DGFs were allowed. On the basis of our analysis of the Myb-deficient phenotype, we expected that Myb would bind considerably more genes in the activated dataset than in the steady-state situation, where only a small proportion of Treg cells express Myb (Figure 2B) . Indeed, we found 2.6-fold more genes with Myb DGFs in activated Treg cells (6,966 genes) than in steady-state Treg cells (2,707 genes; Figure 6C ). Genome-wide analysis of the average DNase I cleavage sites in Treg cells showed a footprint centered on the Myb motif ( Figure 6D ), and 66% of Myb DGFs in steady-state Treg cells were also found in the in-vivo-activated Treg cell dataset ( Figure 6E ).
Analysis of the 1,768 genes that were DE between effector and activated Treg cells, herein referred to the effector Treg cell profile, showed that these genes were much more enriched in Myb DGFs than in the rest of the genome ( Figure 6F ). More than 50% of the effector Treg cell genes had Myb DGFs ( Figures 6F, 6G , and S7F and Table S1 ). This list contained many genes with known functions in effector Treg cells, including the transcriptional regulators Gata3, Bach2, Satb1, Irf4, Maf, and Prdm1 and the effector molecules Ctla4, Klrg1, Icos, Lag3, and Lgals1 ( Figure 6A and Table S1 ). Moreover, for a large proportion of these effector Treg cell genes, chromatin immunoprecipitation (ChIP)-identified Myb binding sites in human T-ALL cell lines correlate with the active chromatin modification H3K27Ac and DHS regions from human Treg cells (examples in Figure S6D ; ENCODE Project Consortium, 2012; Mansour et al., 2014) , suggesting a broad and evolutionary conserved role for Myb in Treg cell differentiation. 
(legend continued on next page)
The complete loss of Myb-deficient effector Treg cells precluded a direct determination of the proportion of effector Treg cell genes regulated by Myb. To overcome this limitation, we identified Myb-dependent genes in activated Treg cells, whose transcriptional trajectory appeared to be in transition between the naive and effector states ( Figure 7A ). The comparison between WT and Myb-deficient activated Treg cells identified 330 Myb-dependent (DE) genes, 43.3% of which belonged to the effector Treg cell profile, whereas 47% had Myb DGFs ( Figures  S7A-S7D and Table S1 ). We found a strong enrichment of Myb-dependent genes among the most regulated genes in the transition from an activated to an effector Treg cell ( Figures  S7A and S7B) . Lgals1, which encodes the immune suppressor galectin-1, is shown as an example of a Myb-dependent gene that has Myb DGFs in mouse Treg cells and binding in human T-lineage cells within the effector Treg cell profile (Mansour et al., 2014; Figures S7A, S7C, and S7E) . Collectively these two approaches demonstrate that Myb directly regulates the expression of a substantial fraction of the effector Treg cell program.
Myb Is Required for the Optimal Proliferation of Effector Treg Cells
We used the PANTHER classification tool of the Gene Ontology (GO) database to perform pathway analysis of the genes that contributed to the effector Treg cell profile and also contained Myb DGFs, which revealed highly significant enrichment for many genes associated with a variety of signaling, protein processing, metabolic, and protein translation pathways, reflective of the changes in metabolic activity associated with the transition between activated and effector Treg cells ( Figure 7A ). This analysis revealed pronounced changes in the subset of genes associated with the cell cycle and apoptosis ( Figures 7A-7C) , two processes that Myb has previously been implicated in (Greig et al., 2008; Lieu et al., 2004) .
Myb DGFs were identified in 38 genes that were associated with the ''apoptotic process'' GO term and DE in effector Treg cells, including downregulation of the anti-apoptotic genes Bcl2 and Mcl1 and upregulation of the pro-death molecules Bak1 and Casp7 ( Figure 7B ). Although these changes suggest an increased apoptotic rate in effector Treg cells, they were balanced by a decrease in Bcl2l11 (Bim) and an increase in Bcl2l1 (Bcl-xL). To assess the impact of Myb deficiency on cell survival, we cultured Treg cells and conventional CD4 + T cells for 2 days in conditions that induce Myb expression ( Figure 2C ) and measured active caspase-3 as a readout for the apoptotic rate. Myb-deficient Treg cells showed a small and statistically significant increase in apoptosis rate, although it is noteworthy that Treg cells of both genotypes were markedly less prone to apoptosis than conventional CD4 + T cells ( Figures 7D and 7E ). 54 genes associated with the ''cell cycle'' GO term also contained Myb DGFs and were DE in effector Treg cells, suggesting that deregulation of the cell cycle might also be a consequence of the absence of Myb ( Figure 7A) . Cdk6, Cdc14a, Cdkn1a, E2f3, E2f4, and Myc are examples of loci identified by this approach ( Figure 7C and Table S1 ). On the basis of these findings, we hypothesized that Myb might be required for the proliferation of effector Treg cells. Indeed, we found that Myb-deficient Treg cells had reduced proliferation capacity in vitro ( Figure 7F) . Moreover, using the 20:80 BM chimeras described above, we found that only the effector Treg subset was actively proliferating, as shown by the proportion of Ki67-expressing cells (Figure 7G 
DISCUSSION
Although the importance of Treg cells for immune homeostasis has been known for two decades, it is only more recently that the diversity of differentiation options of Treg cells has become apparent. Here, we show that the conditional inactivation of the transcription factor Myb in mouse Treg cells results in multi-organ immune pathology and early lethality. Myb plays a stage-dependent role in Treg cells, whereby it is dispensable for their development in the thymus and for their maturation to a ''naive'' phenotype in peripheral tTreg cells but essential for their further differentiation to effector tTreg cells. In contrast, the differentiation of pTreg cells appears to be Myb independent. Genome-wide DNase I footprinting revealed that Myb bound to the regulatory regions of many effector-Treg-cell-specific genes and was required for their expression, demonstrating that Myb is a core component of the tTreg cell differentiation program. Myb is recognized as a critical regulator of hematopoietic stem cell formation and lymphopoiesis; however, its activity in controlling the function of mature blood cells has remained poorly understood (Greig et al., 2008) . Myb is relatively highly expressed (C) Workflow for the identification of Myb DGFs. Genome-wide DHS mapping and DNase I footprints were from GEO: GSM1014200 and 1014148. Myb motifs within footprints were identified de novo and mapped to genes if they occurred within 20 kb of the transcriptional start site and 5 kb downstream of the 3 0 UTR. Table S1 .
(legend on next page) in most BM and thymic progenitors before it is downregulated in mature lymphocytes. Several studies have subsequently demonstrated that Myb is at least transiently re-expressed in activated T and B cells (Gustafsson et al., 2015; Nakata et al., 2010; Sadlon et al., 2010; Xiao et al., 2007) ; however, the importance of this re-expression has not been thoroughly addressed.
The Myb GFP reporter allele we generated confirmed the reexpression of Myb in effector Treg cells in vivo and after the stimulation of naive Treg cells in vitro. RNA-seq analysis revealed little modulation of Myb abundance during Treg cell differentiation, suggesting that the regulation of Myb (and GFP) abundance occurs predominantly post-transcriptionally. miR150, a wellcharacterized regulator of Myb abundance, is highly expressed in naive lymphocytes and repressed upon differentiation (Xiao et al., 2007) and has been shown to repress Myb, but not mRNA abundance, in colonic epithelial cells (Bian et al., 2011) . Thus, we propose that activation of naive Treg cells induces proliferation and the downregulation of miR150, whose loss allows the derepression of Myb in effector Treg cells. Our analysis of Myb DGFs from mouse Treg cells, along with RNA-seq data, revealed a large number of genes whose expression was modulated by this differentiation process and directly bound by Myb. We observed Myb binding in genes involved in effector Treg cell differentiation (Prdm1, Bach2, Batf, and Gata3), localization (Itgae and Ccr7), and function (Icos, Lgals1, and Ctla4) in mice, and this was also evident in human T cell lines. Gata3, a previously characterized target in thymocytes (Maurice et al., 2007) , was also directly regulated by Myb in effector Treg cells. Analysis of mice lacking GATA3 in Treg cells has yielded contradictory findings. Whereas earlier studies reported a function for GATA3 in Treg cell function and for the maintenance of FoxP3 expression (Wang et al., 2011; Wohlfert et al., 2011) , a more recent report has suggested that GATA3 on its own is dispensable for Treg cell function but that mice doubly deficient for GATA3 and T-bet in Treg cells develop severe autoimmunity (Yu et al., 2015) . Although Myb-deficient effector Treg cells failed to upregulate GATA3, they showed normal expression of T-bet, suggesting that the deficiency in GATA3, although likely to contribute, on its own does not fully explain the autoimmune pathology observed.
Prior studies have revealed functions for Myb in regulating cell proliferation and survival. In thymocytes, Myb regulates Bcl2l1 expression , whereas Bcl2 is a Myb target in multiple cell types (Greig et al., 2008) . GO analysis revealed that genes involved in the ''apoptotic process'' were enriched with Myb DGFs and were DE in effector Treg cells. This included Bcl2, Bcl2l1, Bcl2l11, Bak1, Mcl1 , and several members of the TNFR superfamily. Cultured Myb-deficient Treg cells showed a 2-fold increase in their apoptotic rate, which most likely contributes to the loss of effector Treg cells in vivo. Our data also supports a strong role for Myb in promoting the cell cycle. Myb-deficient Treg cells showed a lower proliferative response in vitro and reduced proportion of Ki67 + effector Treg cells in vivo.
Pathway analysis revealed that genes involved in the cell cycle and signal transduction were strongly enriched with direct Myb-target genes, including the cycle promoter Cdk6 and the cell-cycle inhibitor Cdkn1a. Given that the ICOS + TIGIT + effector population harbors most proliferating Treg cells, it is likely that the impaired proliferation and deregulated expression of cellcycle genes is a major functional consequence of Myb loss in Treg cells. It is also noteworthy that Myc, another major regulator of cell proliferation, was downregulated at the transition between activated and effector Treg cells ( Figure 7C ), potentially heightening the effector Treg cell reliance on Myb to promote cell proliferation.
The Recently, it has become apparent that, in addition to the diversity of effector Treg cells observed in adult mice, a functionally distinct compartment of Treg cells is produced early in life (Yang et al., 2015) . Neonatal Treg cells persist into adult life and are important for establishing and maintaining self-tolerance against autoimmune attack in peripheral tissues. In keeping with this model, we observed a very high proportion of either ICOS + TIGIT + or KLRG1
+ effector Treg cells in the blood and tissues such as the 
Foxp3
YFP-cre mice and bulk cultured in the presence of 50 ng/mL PMA (Sigma-Aldrich), 500 ng/mL ionomycin (Sigma-Aldrich), and GolgiStop (BD Biosciences) for 4 hr at 37 C. Cells were stained with fixable viability dye eFluor 506 (eBioscience) and fluorochrome-labeled antibodies against cell-surface CD4 and CD8 and intracellular IFN-g (AN18, generated in house) with the BD Biosciences Cytofix/Cytoperm Fixation/Permeabilization Solution Kit.
RNA-Seq
RNA-seq data were generated and analyzed as described in the Supplemental Experimental Procedures.
Digital Genomic Footprint Analysis DHS sequencing data for steady-state and in-vivo-activated Treg cell samples were downloaded from the Gene Expression Omnibus (GEO: GSM1014200 and 1014148). Sequence reads were mapped to mouse genome mm9 with the Subread aligner. Footprints called for Treg cell samples were downloaded from ENCODE (http://www.uwencode.org/proj/footprints/footprinting.html). Footprint coordinates were provided to the Homer program for de novo discovery of the Myb-binding motif. The discovered motif was then used for identifying the footprints that included the Myb-binding motif. Each Myb-binding footprint was extended from its center by 100 bp from both sides, and the number of mapped reads was counted for each footprint with the featureCounts program. Myb-binding footprints with >3 CPM (counts per million mapped reads) were retained in the analysis. For calling Myb target genes, the filtered list of Mybbinding footprints was assigned to genes. The body of genes was extended 20 kb upstream and 5 kb downstream in the search for Myb-binding footprints. The 5 0 ends of mapped reads surrounding the footprints were used for revealing DNase I cleavage sites at Myb-binding loci.
GO Analysis
GO analysis was carried out with the PANTHER GO-slim classification tool of the GO Reference Genome Project (Mi et al., 2016) .
Statistical Analysis
The statistical significance of non-RNA-seq data was assessed with Prism6 (GraphPad): t tests for all single comparisons were unpaired and assumed Gaussian distribution and equivalent standard deviation (SD); t tests for all multiple comparisons were performed with fewer assumptions (each set was analyzed individually, and consistent SD was not assumed) and corrected by the Holme-Sidak method (a = 0.05). Survival curves were compared with the Long-rank (Mantel-Cox) test. Enrichment of Myb DGFs in datasets was determined with Chi-square tests. p values < 0.05 were considered significant. Bar graphs display the arithmetic mean ± SD unless otherwise stated.
ACCESSION NUMBERS
Raw sequence reads, read counts, and normalized expression values have been deposited into the Gene Expression Omnibus under accession number GEO: GSE72494. 
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